Trends and Outcomes of Aortic Root Enlargement During Bioprosthetic Aortic Valve Replacement
ARE use has increased since commercial approval of VIV. The addition of ARE to AVR did not affect early safety in elective cases, and postoperative gradients were similar to those in patients not requiring ARE. Further studies are required to determine long-term outcomes after ARE, including VIV candidacy.
Authors
- Christopher K. Mehta (ORCID: https://orcid.org/0000-0001-6664-4675)
- Abigail S. Baldridge (ORCID: https://orcid.org/0000-0002-1573-0554)
- Patrick M. McCarthy (ORCID: https://orcid.org/0000-0001-6729-2405)
- Andre Y. Son (ORCID: https://orcid.org/0000-0001-8205-9791)
- S. Chris Malaisrie (ORCID: https://orcid.org/0000-0002-0704-0334)
- Andrei Churyla (ORCID: https://orcid.org/0000-0003-1439-6010)
- Douglas R. Johnston (ORCID: https://orcid.org/0000-0002-2753-8164)
- Duc Thinh Pham (ORCID: https://orcid.org/0000-0003-4443-601X)
Institutions
- Northwestern University (US)
- Northwestern Medicine (US)
Publication Details
- Journal
- Annals of Thoracic Surgery Short Reports
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1016/j.atssr.2024.09.007
- Citations
- 4
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.61